Columbus Circle Investors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Columbus Circle Investors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-87,436	Closed	-$14.4M	–	308
2016 Q3	$14.4M	Sell	87,436 -78,560	-47%	-$12.4M	0.16%	121
2016 Q2	$23.7M	Sell	165,996 -5,050	-3%	-$736K	0.24%	107
2016 Q1	$22M	Sell	171,046 -4,552	-3%	-$537K	0.2%	112
2015 Q4	$26.2M	Sell	175,598 -90,710	-34%	-$15.4M	0.21%	111
2015 Q3	$44.2M	Buy	266,308 +40,977	+18%	+$9.01M	0.36%	72
2015 Q2	$54.4M	Buy	225,331 +90,554	+67%	+$24.1M	0.38%	64
2015 Q1	$38M	Buy	134,777 +41,647	+45%	+$9.02M	0.26%	98
2014 Q4	$14.5M	Sell	93,130 -60,678	-39%	-$11.2M	0.1%	175
2014 Q3	$36.4M	Buy	+153,808	New	+$39.2M	0.26%	95
2014 Q2	–	Sell	-6,120	Closed	-$2.02M	–	307
2014 Q1	$2.02M	Buy	+6,120	New	+$2.07M	0.01%	254

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Columbus Circle Investors's ICPT Position: Q4 2016 in Review

Columbus Circle Investors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2016, closing a stake of 87,436 shares — an estimated $14.4M sold.

Columbus Circle Investors first reported a position in ICPT in Q1 2014 and held it in 10 quarters. The position peaked at $54.4M in Q2 2015. 159 funds tracked by Wall St. Rank hold ICPT as of Q4 2016.

Columbus Circle Investors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Columbus Circle Investors sold 87,436 Intercept Pharmaceuticals, Inc. shares in Q4 2016, an estimated $14.4M.
Columbus Circle Investors first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 10 quarters.
Columbus Circle Investors's Intercept Pharmaceuticals, Inc. position peaked at $54.4M in Q2 2015.
159 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2016.

Based on Columbus Circle Investors's 13F filing for Q4 2016, filed 2 Feb 2017.